Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarilumab + MTX in Japanese RA patients (KAKEHASI)
NCT02293902Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 2014
- Primary completion
- Oct 2016
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of sarilumab in rheumatoid arthritis (RA), sponsored by Sanofi. Started Nov 2014; status: completed.
02
Drugs
sarilumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02293902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02293902.